This article is more than 5 years old. Information may no longer be current.
NHLBI releases new strategic vision
Click Here to Manage Email Alerts
The NHLBI announced eight objectives as part of a new strategic vision that charts the course for research in heart, lung, blood and sleep disorders into the next decade, according to a press release.
The institute had nearly 4,500 individuals from around the world offer input on critical research questions and challenges and formed its objectives based on that feedback.
“The convergence of innovations in areas such as computational biology, data science, bioengineering, and high-throughput ‘omics’ technologies is paving the way for a new appreciation of human health and disease.” Gary H. Gibbons, MD, director of the NHLBI, said in the release. “We now have unprecedented opportunities to better understand the complex interplay of environment, behavioral, and molecular factors that promote health; a clearer picture of the earliest point of disease development; and the ability to repair damaged tissues with stem cell and tissue engineering techniques.”
The eight objectives of the new strategic vision are:
- Understand normal biological function and resilience;
- Investigate newly discovered pathobiological mechanisms relevant to incidence and progression of heart, lung, blood and sleep diseases;
- Investigate factors affecting differences in health among populations;
- Identify factors pertaining to individual differences in pathobiology and in responses to treatments;
- Develop and optimize new diagnostic and therapeutic strategies to prevent, treat and cure heart, lung, blood and sleep diseases;
- Optimize clinical and implementation research;
- Use the latest in data science to open new frontiers in heart, lung, blood and sleep research; and
- Further develop, diversify and sustain a scientific workforce who can accomplish the NHLBI’s mission.
“There is good reason to be hopeful about the future, and, by capitalizing on these developments, the NHLBI’s strategic vision will gives us the best chance of achieving significant progress in improving health for all,” Gibbons said in the release.